Literature DB >> 14999630

Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.

V B Patel1, N Padayatchi, A I Bhigjee, J Allen, B Bhagwan, A A Moodley, T Mthiyane.   

Abstract

Multidrug-resistant (MDR) pulmonary tuberculosis (TB) is well described in the literature. Reports of MDR TB meningitis (MDR-TBM), however, are limited to case reports and a single case series. During the period of 1999-2002, 350 patients with TBM were identified by cerebrospinal fluid culture for TB. Thirty patients (8.6%) had TB that was resistant to at least isoniazid and rifampicin. All 30 patients were included in this study. We reviewed hospital charts of the patients with MDR-TBM and describe our experience. Seventeen patients with MDR-TBM died, and, of those who were known to be alive, many experienced significant morbidity. Eighteen patients were HIV positive. Twenty-two patients had been treated for TB in the past, 3 patients had received no previous treatment for TB, and the history of TB treatment was unknown for 5 patients. The study highlights the prevalence of MDR-TBM and identifies new challenges in the management of affected patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999630     DOI: 10.1086/381973

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Comparative utility of cytokine levels and quantitative RD-1-specific T cell responses for rapid immunodiagnosis of tuberculous meningitis.

Authors:  Vinod B Patel; Ravesh Singh; Cathy Connolly; Victoria Kasprowicz; Thumbi Ndung'u; Keertan Dheda
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

2.  Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study.

Authors:  Christopher Vinnard; Liza King; Sonal Munsiff; Aldo Crossa; Kentaro Iwata; Jotam Pasipanodya; Douglas Proops; Shama Ahuja
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

3.  Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population.

Authors:  Vinod B Patel; Ravesh Singh; Cathy Connolly; Yacoob Coovadia; Abdool K C Peer; Priyashini Parag; Victoria Kasprowicz; Alimuddin Zumla; Thumbi Ndung'u; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-05-04       Impact factor: 21.405

Review 4.  Spinal cord involvement in tuberculous meningitis.

Authors:  R K Garg; H S Malhotra; R Gupta
Journal:  Spinal Cord       Date:  2015-04-21       Impact factor: 2.772

Review 5.  Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients.

Authors:  Christina A Nelson; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2011-09-29       Impact factor: 9.079

Review 6.  Multidrug-resistant tuberculous meningitis.

Authors:  Thomas F Byrd; Larry E Davis
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

7.  Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study.

Authors:  Christopher Vinnard; Carla A Winston; E Paul Wileyto; Rob Roy Macgregor; Gregory P Bisson
Journal:  BMJ       Date:  2010-09-06

Review 8.  A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa.

Authors:  Yohannes W Woldeamanuel; Belaineh Girma
Journal:  J Neurol       Date:  2013-08-21       Impact factor: 4.849

Review 9.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

10.  Underreported threat of multidrug-resistant tuberculosis in Africa.

Authors:  Yanis Ben Amor; Bennett Nemser; Angad Singh; Alyssa Sankin; Neil Schluger
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.